Transaction - Ekso Bionics Holdings, Inc. $973,000,000 M&A Advisory & Fairness Opinion

Lake Street is pleased to announce that it served as financial advisor and provided a fairness opinion to Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) in connection with its merger with the cloud business of Applied Digital Corporation (Nasdaq: APLD). As a result, the cloud business became a wholly owned subsidiary of EKSO, and EKSO changed its name to ChronoScale Corporation ("ChronoScale"). ChronoScale began trading on the Nasdaq Capital Market on Tuesday, May 5, 2026, under the ticker "CHRN" and under a new CUSIP number, 170924104. In addition, the legacy EKSO business will also continue to operate as a wholly owned subsidiary of ChronoScale.

Applied Digital was issued approximately 138 million shares of ChronoScale common stock for the contribution of its cloud business. In addition, Applied Digital invested $15.75 million in cash in ChronoScale for an additional approximately 1.4 million shares of ChronoScale common stock priced at market in a private placement offering, which closed concurrently with the contribution transaction. Following the closing, Applied Digital owns approximately 97% of the outstanding shares of ChronoScale common stock.

‍